The Myelodysplastic Syndromes

Phuong L. Nguyen

Research output: Contribution to journalArticle

19 Citations (Scopus)

Abstract

Myelodysplastic syndromes (MDS) are a heterogeneous group of bone marrow disorders that affect mostly the elderly and have a variable probability of progression to acute leukemia. The diagnosis of MDS rests largely on a critical morphologic review of blood and bone marrow slides, with careful correlation with other clinical and essential laboratory data, including cytogenetics. This article discusses the epidemiology and clinical and pathologic features of MDS and pertinent diagnostic and prognostic classifications, with a brief overview of treatment options. Other considerations in the differential diagnosis are also briefly outlined.

Original languageEnglish (US)
Pages (from-to)675-691
Number of pages17
JournalHematology/Oncology Clinics of North America
Volume23
Issue number4
DOIs
StatePublished - Aug 2009

Fingerprint

Myelodysplastic Syndromes
Bone Marrow
Cytogenetics
Leukemia
Epidemiology
Differential Diagnosis
Therapeutics

Keywords

  • Bone marrow failure
  • Ineffective hematopoiesis
  • Myelodysplastic syndromes
  • Refractory anemia
  • Refractory cytopenia

ASJC Scopus subject areas

  • Hematology
  • Oncology

Cite this

The Myelodysplastic Syndromes. / Nguyen, Phuong L.

In: Hematology/Oncology Clinics of North America, Vol. 23, No. 4, 08.2009, p. 675-691.

Research output: Contribution to journalArticle

Nguyen, Phuong L. / The Myelodysplastic Syndromes. In: Hematology/Oncology Clinics of North America. 2009 ; Vol. 23, No. 4. pp. 675-691.
@article{fa7271b7a251467cbc7fec9ffda6e76c,
title = "The Myelodysplastic Syndromes",
abstract = "Myelodysplastic syndromes (MDS) are a heterogeneous group of bone marrow disorders that affect mostly the elderly and have a variable probability of progression to acute leukemia. The diagnosis of MDS rests largely on a critical morphologic review of blood and bone marrow slides, with careful correlation with other clinical and essential laboratory data, including cytogenetics. This article discusses the epidemiology and clinical and pathologic features of MDS and pertinent diagnostic and prognostic classifications, with a brief overview of treatment options. Other considerations in the differential diagnosis are also briefly outlined.",
keywords = "Bone marrow failure, Ineffective hematopoiesis, Myelodysplastic syndromes, Refractory anemia, Refractory cytopenia",
author = "Nguyen, {Phuong L.}",
year = "2009",
month = "8",
doi = "10.1016/j.hoc.2009.04.008",
language = "English (US)",
volume = "23",
pages = "675--691",
journal = "Hematology/Oncology Clinics of North America",
issn = "0889-8588",
publisher = "W.B. Saunders Ltd",
number = "4",

}

TY - JOUR

T1 - The Myelodysplastic Syndromes

AU - Nguyen, Phuong L.

PY - 2009/8

Y1 - 2009/8

N2 - Myelodysplastic syndromes (MDS) are a heterogeneous group of bone marrow disorders that affect mostly the elderly and have a variable probability of progression to acute leukemia. The diagnosis of MDS rests largely on a critical morphologic review of blood and bone marrow slides, with careful correlation with other clinical and essential laboratory data, including cytogenetics. This article discusses the epidemiology and clinical and pathologic features of MDS and pertinent diagnostic and prognostic classifications, with a brief overview of treatment options. Other considerations in the differential diagnosis are also briefly outlined.

AB - Myelodysplastic syndromes (MDS) are a heterogeneous group of bone marrow disorders that affect mostly the elderly and have a variable probability of progression to acute leukemia. The diagnosis of MDS rests largely on a critical morphologic review of blood and bone marrow slides, with careful correlation with other clinical and essential laboratory data, including cytogenetics. This article discusses the epidemiology and clinical and pathologic features of MDS and pertinent diagnostic and prognostic classifications, with a brief overview of treatment options. Other considerations in the differential diagnosis are also briefly outlined.

KW - Bone marrow failure

KW - Ineffective hematopoiesis

KW - Myelodysplastic syndromes

KW - Refractory anemia

KW - Refractory cytopenia

UR - http://www.scopus.com/inward/record.url?scp=67649639489&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=67649639489&partnerID=8YFLogxK

U2 - 10.1016/j.hoc.2009.04.008

DO - 10.1016/j.hoc.2009.04.008

M3 - Article

C2 - 19577164

AN - SCOPUS:67649639489

VL - 23

SP - 675

EP - 691

JO - Hematology/Oncology Clinics of North America

JF - Hematology/Oncology Clinics of North America

SN - 0889-8588

IS - 4

ER -